Cargando…
A case report of parenchymal hematoma after intravenous thrombolysis in a rivaroxaban-treated patient: Is it a true rivaroxaban hemorrhagic complication?
RATIONALE: To date, the only treatment approved for acute ischemic strokes is thrombolysis. Whether intravenous thrombolysis may be safe in patients taking direct oral anticoagulants (DOACs) is currently a matter of debate. PATIENT CONCERNS: A 74-year-old woman, who was on rivaroxaban 20 mg/d for no...
Autores principales: | Rota, Eugenia, Bruzzone, Gianluca, Agosti, Sergio, Pastorino, Roberto, Morelli, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758276/ https://www.ncbi.nlm.nih.gov/pubmed/29390574 http://dx.doi.org/10.1097/MD.0000000000009435 |
Ejemplares similares
-
Rivaroxaban-associated intracranial hemorrhage in Saudi atrial fibrillation patients
por: Alkhotani, Amal, et al.
Publicado: (2020) -
Intravenous Thrombolysis in a Stroke Patient Receiving Rivaroxaban
por: Fluri, Felix, et al.
Publicado: (2013) -
Predictors of hemorrhagic complications after intravenous thrombolysis in acute cerebral infarction patients: A single-center study of 391 cases
por: Zeng, Jianqi, et al.
Publicado: (2021) -
Intravenous thrombolysis is more safe and effective for posterior circulation stroke: Data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Tong, Xu, et al.
Publicado: (2016) -
Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke: A meta-analysis
por: Liu, Hongfa, et al.
Publicado: (2022)